Cannara Biotech Inc. LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.13% | -24.41% | 75.55% | 100.52% | 182.88% |
| Total Depreciation and Amortization | 9.73% | -1.34% | 4.05% | 2.78% | 2.25% |
| Total Amortization of Deferred Charges | -25.13% | -25.13% | -65.93% | -82.37% | 8.28% |
| Total Other Non-Cash Items | 3,808.53% | 453.70% | 1,355.60% | 3,088.71% | -91.05% |
| Change in Net Operating Assets | -409.28% | 89.23% | -387.03% | -185.13% | 51.93% |
| Cash from Operations | -4.29% | 148.69% | 34.49% | 77.18% | 84.08% |
| Capital Expenditure | -158.72% | -83.08% | -60.64% | 17.09% | 40.57% |
| Sale of Property, Plant, and Equipment | 831.51% | -86.12% | -92.69% | -92.56% | -98.66% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,256.47% | 45.92% | 55.21% | 47.97% | 23.59% |
| Cash from Investing | -213.15% | -177.36% | -150.18% | -11.59% | 22.12% |
| Total Debt Issued | 300.00% | -100.00% | -100.00% | -91.23% | -93.06% |
| Total Debt Repaid | 30.04% | 16.38% | 33.86% | 33.94% | 35.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.39% | 23.28% | 10.48% | 12.54% | 25.13% |
| Cash from Financing | 162.20% | 104.60% | -31.20% | -74.75% | -104.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.59% | 671.65% | -18.76% | 225.64% | 510.47% |